Skip to main content
. 2013 Nov 21;8(11):e81129. doi: 10.1371/journal.pone.0081129

Table 2. Polymorphism in one-carbon metabolism genes and clear cell renal cell carcinoma risk.

Position MAF Cases, n (%) Controls, n (%) P-valuea Adjusted OR (95% CI)b P trenda HWE
CBS
rs1788484 promoter 0.222
CC 535(62.3) 543(54.0) <0.001 Ref. 0.022 <0.001
CT 275(32.0) 425(42.3) 0.62(0.51–0.76)
TT 49(5.7) 37(3.7) 1.27(0.79–2.20)
TT vs. CC+CT 0.038 1.53(0.97–2.41)
CT+TT vs. CC <0.001 0.67(0.55–0.82)
rs706209 3′UTR 0.329
TT 401(46.7) 396(39.4) 0.006 Ref. 0.007 0.379
TC 358(41.7) 480(47.8) 0.76(0.62–0.92)
CC 100(11.6) 129(12.8) 0.74(0.55–1.01)
CC vs. TT+TC 0.434 0.87(0.65–1.16)
TC+CC vs. TT 0.002 0.76(0.62–0.91)
MTRR
rs2966952 promoter 0.333
CC 371(43.2) 463(46.1) 0.120 Ref. 0.064 0.978
CT 374(43.5) 438(43.6) 1.07(0.88–1.31)
TT 114(13.3) 104(10.4) 1.40(1.03–1.91)
TT vs. CC+CT 0.050 1.34(1.00–1.80)
CT+TT vs. CC 0.213 1.13(0.93–1.36)
rs9332 3′UTR 0.188
CC 651(75.8) 708(70.5) 0.027 Ref. 0.007 0.434
CT 196(22.8) 275(27.4) 0.75(0.60–0.93)
TT 12(1.4) 22(2.2) 0.65(0.31–1.33)
TT vs. CC+CT 0.203 0.70(0.34–1.43)
CT+TT vs. CC 0.010 0.74(0.60–0.92)
rs10520873 3′UTR 0.311
AA 593(69.0) 648(64.5) 0.063 Ref. 0.098 0.032
AG 240(27.9) 331(32.9) 0.79(0.64–0.97)
GG 26(3.0) 26(2.6) 1.15(0.65–2.04)
GG vs. AA+AG 0.566 1.24(0.70–2.19)
AG+GG vs. AA 0.038 0.82(0.67–1.00)
TYMS
rs2853741 promoter 0.411
TT 264(30.7) 356(35.4) 0.096 Ref. 0.046 0.982
TC 439(51.1) 484(48.2) 1.25(1.01–1.54)
CC 156(18.2) 165(16.4) 1.24(0.93–1.64)
CC vs. TT+TC 0.321 1.08(0.84–1.39)
TC+CC vs. TT 0.032 1.25(1.02–1.53)
rs699517 3′UTR 0.3
TT 420(48.9) 537(53.4) 0.108 Ref.
TC 358(41.7) 391(38.9) 1.25(1.02–1.52) 0.035 0.619
CC 81(9.4) 77(7.7) 1.26(0.89–1.78)
CC vs. TT+TC 0.172 1.25(1.03–1.51)
TC+CC vs. TT 0.051 1.15(0.82–1.61)
a

Two-sided χ2-test for either genotype distributions or trend between the cases and controls.

b

genotype-specific ORs were adjusted for age, gender, BMI, smoking status, drinking status, diabetes and hypertension in logistic regression model.